Table 6.

Analysis of cost per patient (€, 2011)

	Non-exposed group	Exposed group	Difference
Base case
Cost of ART during the study period*	3,017.50	2,873.58	143.92
Cost of AEs during the study period	0.00	230.26	−230.26
Average total cost during the study period	3,017.50	3,103.84	−86.34
Total cost per day	25.22	25.94	−0.72
Alternative scenario
Cost of ART during the study period	3,017.50	2,873.58	143.92
Cost of AEs during the study period	0.00	230.26	−230.26
Cost of extra follow-up visit during the study period	0.00	345.83	−345.83
Total cost during the study period	3,017.50	3,449.67	−432.17
Total cost per day	25.22	28.83	−3.61

*Study period = 120 days; ART: antiretroviral therapy; AEs: adverse events.